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Abstract
Introduction Tumour growth has been used to successfully
predict progression-free survival in low-grade glioma. This
systematic review sought to establish the evidence base re-
garding the correlation of volumetric growth rates with histo-
logical diagnosis and potential to predict clinical outcome in
patients with meningioma.
Methods This systematic review was conducted according to
the PRISMA (Preferred Reporting Items for Systematic
Reviews and Meta-Analyses) guidelines. Databases were
searched for full text English articles analysing volumetric
growth rates in patients with a meningioma.
Results Four retrospective cohort studies were accepted, dem-
onstrating limited evidence of significantly different tumour
doubling rates and shapes of growth curves between benign
and atypical meningiomas. Heterogeneity of patient character-
istics and timing of volumetric assessment, both pre- and post-
operatively, limited pooled analysis of the data. No studies
performed statistical analysis to demonstrate the clinical utility
of growth rates in predicting clinical outcome.
Conclusion This systematic review provides limited evidence
in support of the use of volumetric growth rates in meningio-
ma to predict histological diagnosis and clinical outcome to
guide future monitoring and treatment.
Keywords Meningioma . Volumetric .MRI . Histology .
Progression-Free Survival
Introduction
Meningiomas originate from the arachnoid cap cells, which
are found in the meninges that surround the brain and spinal
cord. Meningiomas are thought to be the most common be-
nign intracranial tumour [20]. The World Health Organisation
(WHO) classification system for brain tumours, including me-
ningiomas, was first published in 1979 with the latest edition
published in 2016. This and the immediately preceding (2007)
WHO classifications do not differ in their grading of menin-
giomas into benign (grade I), atypical (grade II) and anaplastic
(grade III) [13]. A comparative table of histological grading of
meningioma is shown in Table 1 [1, 22]. Research has shown
that higher-grade tumours are associated with a higher rate of
recurrence and a poorer prognosis [24]. Histologically, these
tumours have higher mitotic activity and cellular atypia [1].
However, in some cases, benign meningiomas have also been
shown to have relatively rapid growth and recurrence after
total removal [12, 15].
In addition to histological diagnosis, growth rate has been
found to serve as significant prognostic factor in low grade
glioma [19]. We hypothesised that this could be similarly use-
ful in the longitudinal management of patients with meningi-
omas. We thus sought to design a systematic review to ascer-
tain the current evidence base for the prognostic value of
spontaneous volumetric growth of meningiomas as seen on
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MRI. We also aimed to establish the relationship between the
rate of meningioma growth and the underlying WHO menin-
gioma histological grades and identify whether the combina-
tion of these two parameters has been used to predict recur-
rence, overall survival and anaplastic transformation.
Methods
This systematic review was conducted according to PRISMA
guidelines and has been registered with the PROSPERO in-
ternational prospective register of systematic reviews (regis-
tration number CRD42016027746).
Search strategy
A systematic search of keywords in Table 2 was performed
independently by two authors (DMF andWCS) ofMEDLINE
Complete, EMBASE 1974 to 2015 via Ovid and the Cochrane
Central Register of Controlled Trials (CENTRAL) via the
Cochrane Library on the 1st January 2016. A record of our
MEDLINE search is provided in the Supplementary Material
(Table S1).
Initially titles and abstracts were screened for relevant
papers by two authors independently (DMF and WCS).
Decisions were blinded and, where disagreements oc-
curred, both authors discussed the disparities and re-
solved them throughout the selection process. The
bibliographies of accepted papers were also examined
for additional articles not identified in the systematic
search. The inclusion criteria, designed using the PICO
(Patient and Problem, Intervention, Comparators,
Outcomes) process, were as follows:
& Study design: Randomised controlled trials, controlled
clinical trials, prospective and retrospective observational
studies were included conditional upon a sample size > 10
patients from the population of interest. We excluded stud-
ies with smaller sample sizes, such as case reports and case
series, on the grounds of a potential publication bias risk.
Only full articles in English language were included, with
articles in other languages, conference abstracts and grey
literature excluded.
& Population: All studies including human subjects with a
meningioma.
& Intervention: Patients underwent imaging with accompa-
nied volumetric growth analysis.
& Outcome: All studies investigating correlation rates of
growth analysis with histological diagnosis, progression-
free and overall survival, recurrence rate and rates of ana-
plastic transformation were included.
Data extraction was also performed by two authors
(DMF and WCS) to ensure reliability. Forward and
backward searching of included studies provided one
further study not identified in the database search.
Table 1 Overview of meningioma grading according to the WHO classifications used in the included studies
Classification I II III
1979 Histologic sub-types included meningotheliomatous, fibrous, transitional, psammomatous, angiomatous, haemangioblastic*,
haemangiopericytic*, papillary, and anaplastic.
Six histologic parameters, each graded 0–3 points, with the overall score below determining the grade of the tumour:
1. Loss of architecture
2. Increased cellularity
3. Nuclear pleomorphism
4. Mitotic figures
5. Focal necroses
6. Brain infiltration (present =3, absent =0)
0–2 points 3–6 points 7–11 points
1993 Histologic sub-types added included microcystic, secretory, clear cell, chordoid, lymphoplasmacytic, metaplastic, atypical.
Haemangioblastic and haemangiopericytic sub-types removed.
2000 1. Histological
sub-type
2. Lack of
anaplastic
features
1. Choroid / clear cell histologic sub-type
2. 4–19 mitosis per ten high-power field (HPF)
3. Three or more of 5 features (small cell change, increased
cellularity, prominent nucleoli, sheet-like growth, or necrosis)
1. Rhabdoid (added to classification) / papillary
histologic sub-type
2. Histological picture of frank malignancy
resembling carcinoma / melanoma / high grade
sarcoma
3. >20 mitosis per ten HPF
2007 Fourth criteria added:
4. Brain infiltrative and otherwise benign meningiomas
* These tumours were excluded in the Jaaskelainen series as they were considered to be different tumours. They were subsequently removed in the 1993
classification as shown in the table
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Results
Our search strategy identified a total of 1,983 articles for
screening. After excluding duplicates and irrelevant studies,
we obtained 24 full articles for further assessment of eligibil-
ity. Of these, 21 were excluded mainly because the studies did
not include volumetric growth rates or the volumetric growth
rates were not directly correlated with the outcomes (Fig. 1).
Four retrospective cohort studies with a total of 151 patients
met the inclusion and exclusion criteria for the systematic
review. As such, they were all classified as evidence level 2b
[8]. Table 3 shows a summary of the four studies that have
been included in the analysis.
Volumetric calculation methods
The methods used for volumetric measurements varied be-
tween studies. Jääskeläinen et al. [10] used computed planim-
eter to measure the volumetric growth rates on CT images
whereas Nakasu et al. [16, 17] performed volumetric measure-
ments on CT and MRI images using the National Institutes of
Health (Bethesda, MD) Image 1.62 software. Nakamura et al.
determined the mean volume from three volumetric measure-
ments using the National Institutes of Health Scion Image J
programme [14].
Histology grades
Only Nakasu et al. 2011 [17] cited the revised 2007 World
Health Organisation (WHO) classification system. It is as-
sumed authors used the 2007 classification system when
assessing the histology of the tumours although the patients
included in their study had resection of their meningiomas
from 1980 to 2004. The rest of the studies correlated the
volumetric growth rates with the pre-2007 WHO histology
grading.
Of the available histological grades, there were 81 grade I
or benign meningiomas, 21 grade II or atypical meningiomas
and 7 grade III or malignant meningiomas. Histology was not
available in 38 cases as the patients were asymptomatic and
did not undergo biopsy or resection of their tumours. Two
studies undertook growth rate analysis post-operatively;
whilst Jääskeläinen et al. reported growth rates following re-
currence after radical removal [10], Nakamura reported
growth rates following identification of remnant tumour
post-operatively [14]. Whilst Nakasu et al. 2005 reported
pre-operative volumes [16], Nakasu et al. 2011 analysed a
combination of asymptomatic and post-operative meningio-
ma, the latter either as a remnant or a recurrence [17].
Jääskeläinen et al. reported that four benign meningiomas
transformed into atypical meningiomas and four atypical tu-
mours transformed into malignant meningiomas [10]. In the
2005 study by Nakasu et al., the authors described eight out of
nine Grade I and one out of four Grade II meningiomas pre-
senting as regrowth, the remaining presenting as recurrence
[16].
Mean growth rates and tumour doubling time
The mean growth rates (cm3/year) were only specified in
Nakamura et al., reporting significantly higher rates in grade
II meningioma relative to grade I [14]. The tumour doubling
time in days were specified in three of the four studies.
Jääskeläinen identified a significantly shorter tumour dou-
bling time between grade I and grade II or III tumours,[10]
which was consistent with findings in Nakamura reporting
significantly higher growth rates in grade II meningioma [14].
The pattern of growth also showed evidence of utility in
predicting histological grade. It was reported that atypical
Table 2 Terms used in the
systematic search. MeSH terms
are shaded in grey
Diagnosis Modality Imaging Measurement Outcome Measure
Meningioma Magnetic Resonance Imaging Grow* Disease Progression
Meningioma* Tomography, X-Ray Computed Morpholog* Disease-Free Survival
MRI Volum* Prognosis
MR Imaging feature* Survival
Magnetic Resonance Imaging Recurrence
CT Neoplasm Grading
Computed Tomography Histology
Histolog*
Histopatholog*
Prognosis
Survival
Recurrence
Anaplastic Transformation
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meningiomas tend to grow quasi-exponentially and a majority
of benign or asymptomatic meningiomas had already passed
the inflection point prior to diagnosis [10, 17]. The majority of
grade I meningiomas begun to slow their growth before the
age of 80 years when compared with the growth of atypical
meningiomas which did not significantly show deceleration
(p = 0.04) [17]. Using regression analysis, the authors showed
that the growth curves of meningiomas fitted the logistic and
sigmoid Gompertzian curves. In addition, the authors also
demonstrated that the growth rates of benign meningiomas
may change in the long term and it is vital to apply the correct
growth model to predict tumour growth and guide the
decision-making process.
Other findings
Nakamura et al. highlighted that the growth rates of benign
meningiomas vary widely even among grade I meningiomas
[14]. Factors associated with an increased volumetric growth
rate include younger age at diagnosis [14], lack of
calcification on radiological scans [16] and the presence of
hyper-intense T2 signals on MRI [14].
Table 4 presents twelve studies that did not meet the inclu-
sion or exclusion criteria but we felt that the findings of the
papers should be reviewed as volumetric growth rates were
performed in these studies. The demographic data could not
be summarised as they are not uniformly available. Two out
of twelve studies investigated volumetric growth rates in neu-
rofibromatosis type 2-associated meningiomas [3, 5]. Evers
et al. showed that in patients with NF2-associated meningio-
mas, tumours in the skull base have higher absolute growth
rates when compared to convexity and ‘other’ meningiomas
[5]. In the study by Dirks et al., the authors found that younger
age at diagnosis (p = 0.01) and female gender (p = 0.05) signif-
icantly contributed to increased volumetric growth rates [3].
Two studies demonstrated that computer-aided volumetric
growth analysis is significantly more superior to traditional
methods in assessing tumour growth [2, 27]. There were eight
different methods used for performing volumetric growth
rates in these studies as demonstrated in Table 4. Two studies
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Table 3 Summary of Accepted Studies M = Male, F = Female. Inflection point refers to point on a curve at which the curve changes from concave
convex or vice versa
Study Population (n, sex,
age, histology)
WHO
Classification
Method Used for
Volumetric Calculation
Doubling time
(mean days)
Outcome measure
(histology,
recurrence)
Findings
Jääskeläinen
et al.
1985[10]
43 (14 M, 29 F),
mean age 47 years
(range 16–65)
Benign – 24
Atypical – 12
Malignant - 7
Corresponding
to 1979
grading
Post-operative recurrence
after radical removal
measured via CT - area
of tumour measured
using computed pla-
nimeter and multiplied
by slice thickness.
Grade I - 415
(range
138–1,045)
Grade II - 178
(range
34–551)
Grade III -
205 (range
30–472)
Compared to initial
resection, 4
benign tumours
became atypical
and 4 anaplastic
tumours became
malignant.
Highly significant
difference between
grade I and grade II-III
(Kruskal-Wallis
one-way ANOVA
p < 0.001), but not be-
tween grades II and III.
Correlation between the
mitotic index and the
doubling time highly
significant (Spearman
rank correlation coeffi-
cient r = − 0.519,
p < 0.001). Atypical
meningiomas tend to
grow quasi--
exponentially. 23/31
asymptomatic meningi-
omas had already
passed the inflection
point prior to diagnosis.
Nakamura
et al.
2005[13]
36 (10 M, 26 F)
Grade I – 33 (7 M,
26 F. Mean age
53.14, range
33–79) Grade II - 3
(3 M. Mean age
45.5, range 37–60)
2000* Post-operative with
remnant tumours
determined using areas
measured on MRI / CT
using NIH image pro-
gramme (Scion image
J) multiplied by slice
thickness. Each volume
measured three times,
and the mean value cal-
culated.
Grade I = 1908
(median)
Grade
II = 204 (me-
dian)
Mean absolute
annual growth
rate: Grade I
=1.51 cm3/year
Grade
II = 23.3 cm3/y-
ear
Growth rates may wary
widely even among
Grade I meningiomas.
Growth rates for
younger patients and
Grade II meningiomas
are significantly higher.
Hypo or iso-intense T2
signals and/or presence
of calcification on MRI
correlate with a lower
growth rate.
Nakasu et al.
2005[15]
20 (5 M, 15 F),
median age 55
Grade I – 9 Grade
II – 4 Histology
not available – 7
2000 Pre-operative volumes
determined using areas
measured on MRI / CT
using National
Institutes of Health
(Bethesda, MD) Image
1.62 multiplied by slice
thickness. Each volume
measured three times,
and the mean value cal-
culated.
Benign – 2,198
Atypical –
322 Incidental
– 3,223
Grade I – 8
regrowth, 1
recurrence
Grade II – 1
regrowth, 3
recurrence
Growth curves of atypical
meningiomas fitted
better to the exponential
curve (R > 0.94).
Although
post-resection re--
growth was faster than
pre-resection in three
patients, this was not
statistically significant
(Wilcoxon
matched-pairs test,
p = 0.14). Meningiomas
without calcification are
likely to grow expo-
nentially.
Nakasu et al.
2011[16]
52 (13 M, 39 F),
median age 57.6
31 –
Asymptomatic 21
– Post-operative
(Grade I – 15,
Grade II – 6)
2007 Asymptomatic and
post-operative volumes
determined using areas
measured on MRI / CT
using National
Institutes of Health
(Bethesda, MD) Image
1.62 multiplied by slice
thickness. Each volume
N/A One benign tumour
enlarged about 8
times during the
first 79 months.
Atypical meningiomas
unlikely to pass point of
tumour growth
deceleration compared
with benign
meningiomas (log-rank
test, p = 0.04). No
difference of patient’s
age at inflection point
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used the ellipsoid formula (a × b × c)/2 whereby a, b and c
represent the maximum width, length and height respectively
to calculate the tumour volume [3, 27]. Information on histo-
logical grading of the meningiomas was only reported in one
study [9]. The mean relative growth rates and tumour dou-
bling time are not comparable due to the heterogeneity of
the reported data.
Discussion
The majority of meningiomas are generally benign and slow-
growing tumours. In clinical practise, tumour growth together
with the presence of symptoms are the main determining fac-
tors of the frequency of follow-up, both pre- and post-opera-
tively, and help guide the clinical management decision-
making process. Nevertheless, there remains limited informa-
tion in the literature regarding the growth rates of meningio-
ma. A range of imaging methods is available for assessing and
monitoring growth and disease progression [2, 5, 6, 18].
Volumetric measurements have been found to be superior to
traditional planimetric methods in assessing tumour growth
kinetics. This has been proposed to be due to tumours being
three-dimensional structures that may grow in various direc-
tions and not just in the planimetric axes [2, 23].
When reviewing evidence on radiological follow-up of
low-grade gliomas, Pallud et al. found that there remains a
question as to whether growth should be monitored over time
in diameter or in volume [19]. This is due to the fact that the
tumour volumes do not usually increase linearly when com-
pared with tumour diameter. The authors proposed that the
linearity of diameter growth curves will allow the analysis of
biological aggressiveness to be more straightforward. The tu-
mour volumes can be converted into diameter using the for-
mula Mean Tumour Diameter (MTD) = (2 × Volume)1/3. The
MTD can then be used to calculate the velocity of diametric
expansion (VDE) by plotting the MTD and performing a lin-
ear regression of VDE over time [19]. The authors concluded
that spontaneous VDE carries a strong prognostic significance
with regards to progression-free and overall survivals in pa-
tient with low-grade glioma. There is currently no evidence if
this metric is applicable to meningiomas.
According to the CBTRUS statistical report, the incidence
of meningioma increases with age but there is no specific
mention as to whether older age at initial diagnosis correlates
with higher-grade meningioma [4]. However, Park JS et al.
has shown that the combined incidence of WHO grade II and
III increases as age advances [21]. Several studies have dem-
onstrated that a higher tumour volume at initial diagnosis is
significantly associated with a higher rate of tumour recur-
rence [2, 26]. However, little is known regarding the volume
of the tumour and the probability that the tumour is of a higher
grade. Using diffusion-tensor MR imaging, Wang et al.
showed that there is significant difference in tumour vol-
ume between atypical and benign meningioma. Atypical
meningioma tended to be larger when compared to benign
meningioma [25].
Our review has indicated that the growth rates of meningi-
omas may evolve over time and vary even among grade I
meningiomas [14, 15]. Jääskeläinen et al. and Nakamura
et al. showed that higher-grade tumours are significantly more
likely to have higher growth rates and shorter tumour doubling
times [10]. However, these studies have correlated the volu-
metric growth rates with the old WHO classification of me-
ningiomas. None of the studies attempted to correlate the
growth rates of meningiomas with the revised 2007 WHO
classification ofmeningiomas.Moreover, the findings of these
studies are limited by the small number of patients and their
retrospective nature. A reliable method to evaluate spontane-
ous growth rates of meningiomas onMRI should be utilised to
determine its usefulness in determining the frequency of fol-
low-ups, determine progression-free survival, treatment
Table 3 (continued)
Study Population (n, sex,
age, histology)
WHO
Classification
Method Used for
Volumetric Calculation
Doubling time
(mean days)
Outcome measure
(histology,
recurrence)
Findings
measured three times,
and the mean value cal-
culated.
between symptomatic
and asymptomatic
meningiomas. Benign
meningiomas may pass
the inflection point and
approach their plateau
volume in the long run,
while atypical
meningiomas are not
likely to do so.
*This is assumed as the text does not explicitly state this and no classification is cited
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efficacy and, possibly, the probability of recurrence or re-
growth after resection.
With regards to the growth rate of non-operated tu-
mours, Zeidman et al. showed that there was no signifi-
cant association between age, gender, or radiological char-
acteristics and volumetric growth [27]. These results need
to be considered in the context of the cohort size of only
21 patients. In a multi-variate analysis of a slightly larger
series (N = 37) by Yoneoka et al., tumour growth was
significantly higher in younger patients and in patients
with a higher volume of tumour at initial diagnosis [26].
When looking at the natural history of 273 intracranial
meningiomas, Oya et al. demonstrated that volumetric
growth rate was seen in 74% of cases. Factors such as
male sex, initial tumour diameter greater than 25 mm,
MR imaging T2 hyperintensity, presence of symptoms
and oedema are significantly associated with higher annu-
al growth rate [18]. Interestingly, Evers et al. demonstrat-
ed that in patients with neurofibromatosis type-2 menin-
giomas, skull base tumours have higher growth rates com-
pared with convexity and other locations whereas
Hashimoto et al. demonstrated that in non-NF2 related
meningiomas, tumour doubling-time was significantly
lower in non-skull base tumours [5, 7].
Limitations
The review was limited by the level of evidence in accepted
studies, with four retrospective cohort studies accepted.
Heterogeneity of patient demographics and the timing of vol-
ume measurement prevented pooled analysis of the data.
None of the studies undertook statistical analysis to investi-
gate the potential for volumetric growth rates to act as a pre-
dictor of histological diagnosis or clinical outcome, restricting
to demonstrating significant differences between histological
diagnoses.
Conclusion
Tumour volumetric growth rates were hypothesised to be a
potentially useful indicator of histological diagnosis and prog-
nosis in patients with meningioma. This systematic review of
volumetric growth rates in patients with meningioma identi-
fied four retrospective cohort studies providing limited evi-
dence in favour of the correlation of volumetric growth rates
with histological diagnosis. None of the accepted studies ex-
tended this analysis to evaluate the potential to predict clinical
outcome. This study highlighted a knowledge gap that is
ready to be addressed as digital acquisition and storage of
radiological imaging has been widely available for over a
decade in most neurosurgical centres.
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